Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taliaz
Tel Aviv–Yafo, Tel Aviv District, Israelpsy.healthcare ↗
- Ownership
- Private
- Employees
- ~14
- Development stage
- Commercial
01
Overview
Taliaz develops PREDICTIX, a CE-marked AI-powered clinical decision-support software that helps psychiatrists and general practitioners personalize antidepressant prescriptions. By integrating genetic, metabolic, demographic, and clinical data using machine learning algorithms, PREDICTIX improves prescribing accuracy by up to 47% compared to standard care. The technology has been validated through retrospective analysis of large-scale studies such as STAR*D. PREDICTIX Genetics combines DNA analysis with AI to optimize treatment selection further. The solution aims to accelerate recovery rates in depression by helping clinicians select the most effective medication from the outset.
- Therapeutic areas
- Psychiatry
- Modalities
- Non-pharmacological therapy (decision support software)Device (digital health platform/software)Artificial intelligence-based toolGenetic testing/analysis platform
- Industry
- Digital Health Medical Devices
02
Partnerships
Cerba HealthCare – partnership for global market entry of PREDICTIX in precision psychiatry/depression managementGenetic Technologies Ltd – exclusive distribution agreement for Australia/New Zealand and non-exclusive rights in USA
Beyond the preview
Go deeper on Taliaz.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Taliaz.